TMBIM6 and lung carcinoma: Given the observed upregulation of TMBIM6 in breast, prostate, cervical, and lung cancers (Fig. 1a–d), changes in metabolism mediated by mTORC2 and especially AKT are likely a major mechanism for cancer progression.